Clinical Trial Update: Registering Genomics and Imaging of Tumors (ReGIT)

View source ↗

Summary

The ReGIT trial (Registering Genomics and Imaging of Tumors) is currently recruiting patients with glioma, sponsored by Indiana University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: Indiana University | Conditions: Glioma | Status: RECRUITING